The level of Lp(a) ≥ 30 mg/dl detected in 60% of the patients with early manifestation of CHD and MACE in comparison with 45% of the patients without MACE is presented, with p < 0.05 (Figure 2). The gene discussed is LPA; the disease is coronary artery disorder.